Dr. Cheng H Lo, M.D. Surgery - Vascular Surgery Medicare: Medicare Enrolled Practice Location: Va Medical Center, 79 Middleville Rd, Northport, NY 11768 Phone: 631-621-4400 |
Chanak Chantachote, M.D. Surgery - Surgical Critical Care Medicare: Not Enrolled in Medicare Practice Location: Department Of Surgery, 79 Middleville Rd, Northport, NY 11725 Phone: 631-261-4400 |
Dr. Andrew J Rochman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5 Pebble Hill Dr, Suite 205, Northport, NY 11768 Phone: 516-521-9937 Fax: 516-521-9937 |
Dr. Soojin Ahn, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 79 Middleville Rd, Surgical Services, Northport, NY 11768 Phone: 631-233-2317 |
News Archive
Eli Lilly and Company today announced that it has completed the acquisition of Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intended for the detection and monitoring of chronic human diseases. The transaction, first announced on November 8, 2010, has received the approval of Avid stockholders and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. All other closing conditions have also been met.
A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases.
UNFPA Executive Director Babatunde Osotimehin on Tuesday told the Associated Press that the world should focus more on family planning issues, stating that "'family planning seems to have fallen off the radar' in the past two decades - a victim of politics, funding shortages and focus on other priorities such as fighting AIDS," the news service reports.
Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for FORTESTA(TM) (testosterone) 2% Gel for men diagnosed with low testosterone (Low T), also known as hypogonadism.
A hospital's evaluation trial of the SwabCap™ disinfection cap for needleless IV connectors showed the cap achieved compliance with a new Joint Commission requirement, according to a poster to be presented at the National Patient Safety Foundation Annual Congress.
› Verified 9 days ago